Treating migraine headaches with or without aura (eg, flashing lights, wavy lines, dark spots). It should not be used to prevent migraines or to treat cluster headaches.
Maxalt-MLT orally disintegrating tablets are a serotonin 5-HT1receptor agonist (“triptan”). It works by narrowing dilated blood vessels in the brain, relieving migraine headaches.
Submit your review
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Dizziness; drowsiness; dry mouth; fatigue; nausea; weakness.
Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bloody diarrhea; burning, numbness, or tingling of the hands or feet; chest heaviness; chest, neck, or jaw pain, tightness, or pressure; decreased coordination; excessive sweating; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; mental or mood changes (eg, agitation); muscle spasms; seizure; severe nausea, vomiting, or diarrhea; severe or persistent headache or dizziness; shortness of breath; stomach pain; symptoms of stroke (eg, confusion, one-sided weakness, slurred speech); tremor; unusual weakness; very cold or blue fingers or toes; vision changes or loss of vision.
Dosing Information in Adults The recommended starting dose of MAXALT is either 5 mg or 10 mg for the acute treatment of migraines in adults. The 10-mg dose may provide a greater effect than the 5-mg dose, but may have a greater risk of adverse reactions. Although the effectiveness of a second dose or subsequent doses has not been established in placebo-controlled trials, if the migraine headache returns, a second dose may be administered 2 hours after the first dose. The maximum daily dose should not exceed 30 mg in any 24-hour period. The safety of treating, on average, more than four headaches in a 30-day period has not been established. Dosing Information in Pediatric Patients (Age 6 to 17 Years) Dosing in pediatric patients is based on the patient’s body weight. The recommended dose of MAXALT is 5 mg in patients weighing less than 40 kg (88 lb), and 10 mg in patients weighing 40 kg (88 lb) or more. The efficacy and safety of treatment with more than one dose of MAXALT within 24 hours in pediatric patients 6 to 17 years of age have not been established.